Abstract

Some extracellular proteins are initially secreted in reduced forms via a non-canonical pathway bypassing the endoplasmic reticulum and become oxidized in the extracellular space. One such protein is HMGB1 (high-mobility group box 1). Extracellular HMGB1 has different redox states that play distinct roles in inflammation. Using a unique NMR-based approach, we have investigated the kinetics of HMGB1 oxidation and the half-lives of all-thiol and disulfide HMGB1 species in serum, saliva, and cell culture medium. In this approach, salt-free lyophilized (15)N-labeled all-thiol HMGB1 was dissolved in actual extracellular fluids, and the oxidation and clearance kinetics were monitored in situ by recording a series of heteronuclear (1)H-(15)N correlation spectra. We found that the half-life depends significantly on the extracellular environment. For example, the half-life of all-thiol HMGB1 ranged from ~17 min (in human serum and saliva) to 3 h (in prostate cancer cell culture medium). Furthermore, the binding of ligands (glycyrrhizin and heparin) to HMGB1 significantly modulated the oxidation kinetics. Thus, the balance between the roles of all-thiol and disulfide HMGB1 proteins depends significantly on the extracellular environment and can also be artificially modulated by ligands. This is important because extracellular HMGB1 has been suggested as a therapeutic target for inflammatory diseases and cancer. Our work demonstrates that the in situ protein NMR approach is powerful for investigating the behavior of proteins in actual extracellular fluids containing an enormous number of different molecules.

Highlights

  • Redox of extracellular HMGB1 protein plays an important role in inflammation

  • Salt-free lyophilized 15Nlabeled all-thiol HMGB1 was dissolved in actual extracellular fluids, and the oxidation and clearance kinetics were monitored in situ by recording a series of heteronuclear 1H-15N correlation spectra

  • In this study, using a unique NMR-based approach, we investigated the kinetics of HMGB1 oxidation and the half-lives of all-thiol and disulfide HMGB1 proteins in actual extracellular fluids: serum, saliva, and cell culture medium

Read more

Summary

Background

Redox of extracellular HMGB1 protein plays an important role in inflammation. Results: The half-life of all-thiol HMGB1 was ϳ17 min in serum and saliva and significantly longer in cancer cell culture medium and was modulated by exogenous ligands (e.g. heparin). Using a unique NMR-based approach, we have investigated the kinetics of HMGB1 oxidation and the half-lives of all-thiol and disulfide HMGB1 species in serum, saliva, and cell culture medium. We studied the oxidation of HMGB1 (high-mobility group box 1) protein in extracellular fluids This 25-kDa protein, which is normally located in nuclei, is passively released during cell injury and necrosis and actively secreted by some cell types via a non-canonical pathway that bypasses the endoplasmic reticulum [13, 14]. In this study, using a unique NMR-based approach (schematically depicted in Fig. 1B), we investigated the kinetics of HMGB1 oxidation and the half-lives of all-thiol and disulfide HMGB1 proteins in actual extracellular fluids: serum, saliva, and cell culture medium. We studied how oxidation kinetics are affected by exogenous ligands such as heparin, which mimics cell surface heparan sulfate

EXPERIMENTAL PROCEDURES
RESULTS
27 Ϯ 3 84 Ϯ 3 201 Ϯ 6
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call